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The cell surface molecule 2B4 (CD244) is an important regulator of lymphocyte activation, and its role in antiviral
immunity and lymphoproliferative disorders is well established. Although it is also expressed on mast cells (MCs)
and eosinophils (Eos), the functions of 2B4 on these allergy-orchestrating cells remain unclear. We therefore
investigated the role of 2B4 on murine MCs and Eos, particularly how this molecule affects allergic and
nonallergic inflammatory processes involving these effector cells. Experiments in bone marrow–derived cultures
revealed an inhibitory effect for 2B4 in MC degranulation, but also an opposing stimulatory effect in eosinophil
migration and delayed activation. Murine disease models supported the dual 2B4 function: In 2B4 / mice with
nonallergic peritonitis and mild atopic dermatitis (AD), modest infiltrates of Eos into the peritoneum and skin
(respectively) confirmed that 2B4 boosts eosinophil trafficking. In a chronic AD model, 2B4 / mice showed
overdegranulated MCs, confirming the inhibiting 2B4 effect on MC activation. This multifunctional 2B4 profile
unfolded in inflammation resembles a similar mixed effect of 2B4 in natural killer cells. Taken together, our
findings provide evidence for physiological 2B4 stimulatory/inhibitory effects in MCs and Eos, pointing to a
complex role for 2B4 in allergy.
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INTRODUCTION
2B4 (CD244) is a CD2-family surface molecule with multiple
activities, and it is typically found on natural killer (NK) cells
and T lymphocytes (McNerney et al., 2005; Vaidya and
Mathew, 2006; Veillette, 2006; Waggoner and Kumar,
2012). 2B4 was first described as a stimulator of NK
cytotoxicity IFN-g secretion, as discovered by specific
antibody (Ab) binding (i.e., cross-linking) of the molecule in
mouse (Garni-Wagner et al., 1993; Mathew et al., 1993) and
human (Valiante and Trinchieri, 1993; Chuang et al., 2001)
NK cultures. The activating role for 2B4 on NK cells surfaced
also upon engagement with its natural high-affinity ligand
CD48, a CD2-family glycosyl–phosphatidyl–inositol-anchored
protein (Yokoyama et al., 1991; Brown et al., 1998;
Elishmereni and Levi-Schaffer, 2011), on human (Tangye
et al., 2000) and mouse (Bloch-Queyrat et al., 2005; Lee
et al., 2006) target cells. Nevertheless, inhibitory 2B4 pheno-
types also exist, predominantly in mice: ligation of 2B4 on
murine NK cells by CD48þ cells (e.g., tumor cells, dendritic
cells, and activated T cells) hampers the NK killing potential,
an inhibitory effect that is lost in 2B4-lacking NK cells (Lee
et al., 2004; McNerney et al., 2005; Morandi et al., 2005;
Vaidya et al., 2005; Vaidya and Mathew, 2006; Chlewicki
et al., 2008; Waggoner et al., 2010).
Despite the growing knowledge on the multiple functions of
2B4 in lymphocytes and NK cells, its particular role in allergy
and on its key effector cells, mast cells (MCs) especially in the
early phase, and eosinophils (Eos) in the late/chronic stage
(Galli et al., 2008; Hogan et al., 2008), is unclear. Indeed, 2B4
expression on human peripheral blood Eos was established in
our earlier studies (Munitz et al., 2005). In these human cells,
2B4 triggers Eos degranulation and release of IFN-g and IL-4
(Munitz et al., 2005), and it boosts Eos viability (Elishmereni
et al., 2011). 2B4 has more recently been implicated also in
human Eos adhesion and migration (El-Shazly et al., 2011).
Human MCs, however, do not express 2B4 (Munitz et al.,
2005) but rather its ligand CD48 (Malaviya et al., 1999;
Malaviya and Georges, 2002). Interestingly, in the murine
setting, 2B4 appears on both MCs and Eos (Kubota, 2002;
Elishmereni et al., 2013), yet its functionality in the mouse
system has not been properly dissected, neither in vitro nor
in vivo. Given the complex 2B4 pattern in murine/human NK
cells (Vaidya and Mathew, 2006; Chlewicki et al., 2008), the
question of whether 2B4 is inhibiting and/or activating in
murine MCs and Eos, and as a consequence whether 2B4
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signaling in allergic inflammation is beneficial or detrimental,
remains open.
In the present study, we examined the role of 2B4 on MCs
and Eos in allergic and nonallergic inflammation. Our com-
prehensive analysis used murine MC and Eos cultures
using Ab ligation and inhibition of the molecule, as well as
in cells derived from 2B4-deficient (2B4 / ) mice. The
in vitro effects were confirmed in nonallergic peritonitis and
allergic atopic dermatitis (AD) induced in 2B4 / mice.
Our findings implicate both positive and negative functions for
2B4 in allergic inflammation, aligning with the established
multifunctional role of this regulating receptor in the immune
system.
RESULTS
Inhibitory signal of 2B4 in murine MCs in vitro
To understand how the 2B4 pathway works in murine MCs
and Eos, we first dissected the respective influences of this
receptor on both effector cells in vitro. We examined whether
2B4 activates or inhibits the functions of bone marrow–
derived MCs (BMMCs). Ligation of 2B4, through cross-linking
by a specific monoclonal Ab, inhibited IgE activation of
BMMCs: the cells released lower b-hexosaminidase levels
following dinitrophenyl (DNP) stimulation, as compared with
control (isotype-containing) cultures (Figure 1a). In tandem,
preblocking 2B4 on BMMCs by Abs (to inhibit signaling by
its natural ligand, CD48, on neighboring cells) resulted
in elevated b-hexosaminidase release in both basal and IgE-
activation conditions (Figure 1b). Hence, continuous 2B4
binding in BMMCs (most likely by CD48 on other BMMCs
(Elishmereni et al., 2011)) regulates degranulation. This effect
was apparent primarily under suboptimal levels of DNP, as
2B4 blocking was unable to further augment the already
potent activation in higher (saturating) DNP concentrations
(Figure 1b). To assess whether an inherent deficiency in 2B4
expression on BMMCs affects their activation, we compared
BMMC phenotypes in 2B4 / and wild-type (wt) mice.
2B4-lacking BMMCs developed normally, contained regular
granular amounts, and expressed the characteristic cKit and
FceRI markers, CD48, and other typical adhesion molecules
(Supplementary Figure S1a online). Nonetheless, the 2B4-
knockout BMMCs consistently showed enhanced responses
to IgE stimulation as compared with wt BMMCs (Figure 1c).
The effect of the 2B4 deficiency on activation was strongest in
the saturated DNP concentration (Figure 1c), implying that
2B4-mediated inhibition of BMMCs may be proportional to
the degree of their activation.
Stimulatory signal of 2B4 in murine Eos in vitro
Next, we studied the role of 2B4 on bone marrow–derived Eos
(BMEos). 2B4 stimulation did not modify BMEos degranulation
patterns: Eos peroxidase (EPO) release from 2B4-crosslinked
cells under basal or platelet-activating factor–induced condi-
tions was comparable to that of control (isotype-treated) cells
(Figure 2a). 2B4 blockade by neutralizing Abs (to prevent
CD48 signaling from adjacent Eos) was also inconsequential
to degranulation (Figure 2b). 2B4 absence does not appear to
affect Eos phenotype and maturation: BMEos from 2B4 /
mice developed normally and showed typical expression of
Siglec-F, CCR3, and CD48 (Supplementary Figure S1b online).
Moreover, the 2B4-lacking cells showed intracellular granule
content comparable to that of wt mice (data not shown), and
normal response to platelet-activating factor-mediated activa-
tion (Figure 2c).
To examine the involvement of 2B4 in murine Eos
chemotaxis, we assessed the migration ability of BMEos from
2B4 / mice toward different established stimuli. Com-
pared with wt cells, 2B4-lacking BMEos showed dimi-
nished chemotaxis toward DNP-activated BMMCs or mouse
Eotaxin-1 (Elishmereni et al., 2013), suggesting that 2B4
facilitates trafficking of Eos (Figure 2d). We also examined
whether 2B4 can influence long-term BMEos activation.
Indeed, BMEos ligated with the 2B4 Ab for 48 hours increased
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Figure 1. 2B4 inhibition of BMMCs. (a) b-Hexosaminidase (b-Hex) release
from resting or IgE (DNP)-activated BMMCs that were also ligated with 2B4 Ab
(or control isotype Ab). (b) b-Hex release from resting or IgE (DNP)-activated
BMMCs that were first blocked by a 2B4 Ab (or control isotype Ab). (c) b-Hex
release from resting or IgE (DNP)-activated BMMCs derived from 2B4 /
mice or their wt counterparts. b-Hex was measured by a chromogenic assay
at 405 optical density (OD). All data represent n¼3 experiments and are
shown as mean±SEM (*Po0.05). Ab, antibody; BMMC, bone marrow–
derived mast cell; DNP, dinitrophenyl; NA, not activated; wt, wild-type.
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the expression of the Eos activation marker lysosomal-asso-
ciated membrane protein-1 (LAMP-1; Figures 2e and f),
indicating prolonged stimulation. The Ab binding of 2B4 on
these BMEos was confirmed as steady even after 48 hours, as
2B4 could not be stained by a second PE-conjugated 2B4 Ab
(Figure 2f). The 2B4-induced increase in LAMP–1 was spe-
cific, as other surface markers (Siglec-F, CD48, CCR3, and
CD49d) on these BMEos were unchanged under similar
constant 2B4 ligation (Figure 2f). Thus, 2B4 signaling facil-
itates a persisting activated phenotype in murine Eos.
2B4 effects in nonallergic peritonitis
We tested whether the above in vitro–dissected 2B4 stimula-
tory/inhibitory effects occur also in vivo. Peritonitis was
induced in 2B4 / mice by i.p. challenge with compound
48/80 (c48/80), a MC degranulator causing rapid inflamma-
tion independently of IgE (Das et al., 1997; Ribeiro et al.,
2000). Peritoneal lavages post-challenge showed a minor (yet
insignificant) rise in granulocytes/neutrophils and reduction in
monocytes/lymphocytes (with no differences between wt and
2B4 / mice; Supplementary Figure S2 online), pointing
to a general inflammatory response. Peritoneal MCs (cKitþ
mononuclear-derived cells) were also reduced after challenge
(Figure 3a), likely owing to c48/80-induced degranulation
and/or depletion of MCs (Das et al., 1997; Ribeiro et al.,
2000). MCs were lower even in control 2B4 / mice as
compared with wt mice, implying that 2B4 absence causes
baseline depletion or overdegranulation of MCs, and possibly
indicatng inhibitory 2B4 signals in MCs (as found in vitro).
Challenge also increased the infiltration of Eos (Siglec-Fþ
cells) in wt mice (Figure 3b), as expected in view of the
strong MC activation (Das et al., 1997). Interestingly, how-
ever, this did not occur in diseased 2B4 / mice, where
low peritoneal Eos were found despite highly degranu-
lating MCs. Hence, concomitant with culture experiments,
a 2B4 stimulatory effect on Eos trafficking may exist.
2B4 effects in mild (short-term) AD
To explore the 2B4 duality in allergic inflammation, we used
experimental AD, a disease accompanied by substantial skin
infiltration of MCs and Eos (Savinko et al., 2005). AD was
induced in 2B4 / and wt mice by repeated epicutaneous
sensitization with ovalbumin (OVA) and streptococcal
enterotoxin B (SEB) in a mild vs. chronic model (see
(Savinko et al., 2005; Wang et al., 2007) and Supplementary
Materials and Methods online).
In the mild model (Figure 4a), both mice displayed
characteristic skin remodeling following OVA/SEB treatment.
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This was shown by thickening of the dermis and more so of
the epidermis, although the latter effect was slightly milder in
2B4 / mice (Figure 4b). Serum total IgE was increased in
diseased wt mice, but not in 2B4 / mice (Figure 4c). It is
noteworthy that total IgE was higher in control 2B4 / mice
compared with wt, implying a role for 2B4 in regulating IgE
production. The overall milder inflammation in 2B4 /
mice was observed in other parameters: OVA-specific IgE was
increased in both strains, yet more prominently in wt mice
(Figure 4c). Serum tumor necrosis factor-a (Supplementary
Figure S3a online) and skin-draining lymph node cellular
content (Supplementary Figure S3b online) were also
enhanced in challenged wt (but not 2B4 / ) mice. Similar
trends were observed in serum IFN-g, IL-13, and IL-5, although
not significantly, owing to high variance between individual
mice (Supplementary Figure S3a online; IL-4 levels were
undetectable). Similarly, skin infiltrates of CD3þ , CD4þ ,
and Foxp3þ (regulatory) lymphocytes were higher in diseased
wt, but not in 2B4 / , mice (Figure 4d), with a constant
ratio between T effector cells and T regulatory cells as
recognized in this model (Fyhrquist et al., 2012). However,
other cells such as CD8þ cells and activated (degranulated,
non-dense) MCs were increased in both mouse types under
challenge (Figures 4d and e). Of note, the rise in activated MCs
was probably not due to trafficking, considering the compar-
able total MC counts in all groups (Figure 4e). Infiltration of
skin Eos also appeared in both diseased groups (Figure 4e), yet
the Eos level in 2B4-lacking mice was lower (Figure 4e).
Collectively, most inflammation markers and particularly Eos
responses are hampered under absent 2B4 signaling.
2B4 effects in chronic (long-term) AD
In chronic AD (Figure 5a), stronger skin remodeling was
observed in both strains, as dermal and epidermal thickening
increased similarly (Figure 5b). Both challenged strains also
showed higher total and OVA-specific IgE, even though the
rise in OVA-specific IgE in 2B4 / mice was more minor
(Figure 5c). (Notably, as in mild AD, total IgE in control groups
differed between wt and 2B4 / , yet with greater levels in
wt mice, in contrast to Figure 4c.) Challenged wt mice also
showed higher serum IFN-g and IL-13 levels than 2B4 /
mice (Supplementary Figure S3c online; levels of tumor
necrosis factor-a, IL-4, and IL-5 were undetectable). Similarly,
although skin CD3þ and CD4þ cells were normally
increased in both challenged wt and 2B4 / mice
(Supplementary Figure S4 online; a, b), the 2B4 knockouts
displayed a more modest rise in CD8þ cells, and the
increased Foxp3þ cells observed in wt mice were lacking
in 2B4 / mice (Supplementary Figure S4 online; a, b).
Hence, the absence of 2B4 partially impairs the inflammatory
response also in chronic AD.
Interestingly, activated (but not total) MCs were increased
after OVA/SEB challenge in both mouse strains, yet 2B4 /
mice exhibited significantly higher numbers of these MCs
(Figure 6a). Unlike in mild AD, Eos infiltrates were compar-
able in both mouse types under challenge (Figure 6a). MCs
physically contact Eos to form couples (allergic effector units;
AEU), especially under activated settings, and this
contact occurs partly through 2B4 interactions with CD48
(Elishmereni et al., 2011; Elishmereni et al., 2013). We thus
hypothesized that MC–Eos coupling would be impaired in
2B4-lacking mice under inflammation. The MC–Eos pairing
found in OVA/SEB-challenged wt mice (but not in controls)
was in fact much less abundant in the challenged 2B4 /
mice (Figures 6b and c), even though total MCs and Eos were
similar in both groups, implying that 2B4 is needed for AEU
formation in vivo.
DISCUSSION
The effects of 2B4 have been widely explored in NK cells,
particularly in the context of viral infections, lymphoprolife-
rative disorders, and antitumor responses (Chlewicki et al.,
2008; Waggoner and Kumar, 2012), but not yet in inflamma-
tion and allergic hypersensitivity. We presently demonstrate
the multifaceted role of 2B4 on the main allergic inflammation
effectors MCs and Eos in mice, and expand on the known
functions of 2B4 in human Eos (as summarized in Supple-
mentary Figure S5 online), using a comprehensive approach
integrating in vitro and in vivo models.
We revealed a ‘time-dependent’ stimulatory role for 2B4 in
murine Eos: 2B4 ligation did not induce BMEos degranulation,
but rather a ‘late activation’ phenotype in BMEos (as reflected
by selectively increased LAMP-1). The notion that 2B4 signal-
ing affects delayed Eos functions is supported also by our
previous study, where human Eos were more viable following
a 3-day 2B4 activation (Elishmereni et al., 2011). It is
noteworthy that 2B4 ligation did induce rapid degranulation
of human peripheral blood Eos in our earlier study (Munitz
et al., 2005). However, this effect may not have been observed
in BMEos, because they are not in vitro primed or derived
from atopic individuals (in contrast to human Eos; (Munitz
et al., 2005)). It is also plausible that human and murine Eos
2B4 effects do not coincide, especially as 2B4 functions in
mouse and human NK cells are known to differ (Vaidya and
Mathew, 2006; Chlewicki et al., 2008).
The chemotactic ability of Eos was also dependent on 2B4:
BMEos from 2B4 / mice showed significantly reduced
migration capacity in vitro, consistent with the observed poor
Eos infiltration in 2B4 / mice with peritonitis. The fact that
similar outcomes were found in both disease models indicates
a robust 2B4 effect, likely independent of IgE processes. This is
also supported by the recent finding that 2B4-cross-linking on
human peripheral blood Eos, and on a human Eos cell line,
causes cell adhesion to collagen type IV and increased
migration through tyrosine kinase phosphorylation (El-Shazly
et al., 2011). A similar tyrosine-dependent mechanism may
control 2B4-stimulated Eos chemotaxis also in mice. Further, it
is tempting to speculate that CD48 on endothelial cells (Khan
et al., 2007) may be the trigger for this migration, by binding
to 2B4 on Eos.
At the other end, 2B4 downregulates murine MCs: BMMCs
that were 2B4-blocked, as well as BMMCs from 2B4 /
mice, were more strongly activated. The finding that 2B4 /
mice have normal MC/Eos properties (in concert with normal
hematopoietic phenotypes that these mice present with;
(Lee et al., 2004; McNerney et al., 2005)) suggests that the
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heightened degranulation in 2B4-deficient BMMCs is a direct
result of the missing 2B4 signal, and not a by-product of
anomalous functioning of cells. Low peritoneal MC levels in
2B4 / mice also support a regulating 2B4 signal in these
cells. An inhibitory effect of 2B4 in murine MCs is akin to
its role in murine NK cells (which show lower cytotoxicity
toward CD48þ targets, whereas 2B4-deficient or 2B4-
blocked NK cells present augmented cytotoxicity toward the
same cells (Lee et al., 2004; Vaidya and Mathew, 2006;
Chlewicki et al., 2008)).
The idea that 2B4 has contradicting effects in murine MCs
and Eos is entirely plausible, given the mixed inhibitory/
activatory profiles in NK cells in mice and humans (Vaidya
and Mathew, 2006; Veillette, 2006; Chlewicki et al., 2008). At
least two 2B4 isoforms with distinct functions exist in both
humans (Mathew et al., 2009) and B6 mice (Stepp et al.,
1999). In a rat NK line, inhibitory effects associate with 2B4-L,
the long isoform with four tyrosine motifs in the cytoplasmic
domain (and the equivalent of the human 2B4 isoform
(Veillette, 2006)), whereas 2B4-S (the short one-tyrosine-
motif form) links to activation (Vaidya and Mathew, 2006;
Chlewicki et al., 2008). The 2B4 isoform in human or murine
Eos remains uncharacterized. Interestingly, BMMCs contain a
2B4S isoform (Kubota, 2002), yet the latter differs structurally
from the NK isoform. BMMCs may also contain an
additional undefined 2B4 isoform (Kubota, 2002). How-
ever, given that the 2B4L isoform has opposing functions in
human and murine NK cells, it is unlikely that the 2B4 isoform
alone determines outcome. Rather, the actual phenotype will
depend also on the 2B4 expression density, glycosylation, and
degree of cross-linking (Chlewicki et al., 2008). Indeed,
BMMCs and BMEos express different 2B4 levels (Supplemen-
tary Figure S1 online), and cytokines/chemokines may alter
this expression (El-Shazly et al., 2011). Diverse adaptor
recruitment downstream 2B4 also controls outcome: NK
activation depends on 2B4 binding to SAP (also expressed in
human Eos (Veillette, 2006)), whereas NK inhibition involves
EAT-2, ERT, SHP-1, and SHIP (Vaidya and Mathew, 2006) (the
latter two phosphatases also present in BMMCs; (Gilfillan and
Rivera, 2009)). Future studies should characterize the exact
2B4 sequence variations and signaling molecules underlying
2B4 inhibition of BMMCs and stimulation of BMEos.
Mouse AD mimicking the features of human dermatitis (skin
remodeling, cell hyperplasia, immune infiltration, and so on)
is best induced by repeated topical OVA sensitization, often
together with SEB (Spergel et al., 1998; Savinko et al., 2005;
Wang et al., 2007; Jin et al., 2009). The OVA/SEB model is
MC and Eos-abundant (Savinko et al., 2005), and allergen/SEB
dermatitis models appear to be highly dependent on MCs
(Ando et al., 2013). We were able to induce AD in 2B4 /
mice with significant remodeling and inflammation; however,
the 2B4 deficiency impaired these effects: in the mild model,
systemic inflammatory markers (total and OVA-specific IgE,
cytokines, lymph node content) and local inflammatory
markers (CD3þ , CD4þ , and Foxp3þ cells; Eos) were
diminished in 2B4 / mice. However, in chronic AD,
some of these markers (total IgE, CD3þ and CD4þ cells,
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Eos) were no longer impaired in the absence of 2B4, whereas
other markers (OVA-specific IgE, cytokines, CD8þ , and
Foxp3þ cells) were still hampered. This suggests that 2B4
acts separately on each molecular and cellular component of
inflammation, and the dynamics of its effect differ between
components. Moreover, the 2B4 transcriptional pathway
could also be important for regulation of IgE kinetics,
production, and decay, given that the lack of 2B4 causes
increased IgE levels in mild AD, but lower levels in chronic
AD. Overall, the exact role of 2B4 in AD seems to depend on
the disease stage and severity.
The finding that in mild AD Eos infiltration was hampered in
2B4 / mice, particularly despite the abundance of acti-
vated MCs (which are primary chemoattractants for Eos; (Das
et al., 1998)), provides additional evidence for a stimulating
2B4 signal for Eos trafficking. Strikingly, the 2B4 absence did
not inhibit Eos infiltration in chronic AD, but did elevate
activated MCs, offering support for the 2B4 inhibitory effect
on MC activation. Notably, this overt MC stimulation in
2B4 / mice may explain the restored Eos influx, consi-
dering that MCs are known inducers of Eos chemotaxis
(Das et al., 1998; Hirai et al., 2001; Shakoory et al., 2004).
Thus, the in vivo findings of 2B4-stimulated Eos functions
and 2B4-inhibited MC functions concur with the in vitro
understanding of the dual 2B4 effect.
We recently found that, in humans, direct Eos 2B4 binding
with its cognate ligand CD48 on MCs participates in MC-
induced boosting of Eos viability and in Eos-augmented MC
degranulation (Elishmereni et al., 2011; Elishmereni et al.,
2013). On the basis of this, the 2B4-CD48 axis was nominated
as a prominent component of the AEU, a functional
MC–Eos communication system. Interestingly, the 2B4-CD48
axis is probably conserved in humans and mice, as 2B4
engages CD48 at similar affinities and docking topologies
in both species (Chlewicki et al., 2008). Indeed, 2B4-mediated
contacts between MCs and Eos also appear in mice
(Elishmereni et al., 2011; Elishmereni et al., 2013). It is
therefore not surprising that MC/Eos pairing in chronic AD
is reduced in 2B4-lacking mice, where the 2B4/CD48-binding
platform is missing. We rule out the possibility that this
reduced pairing stems from different cell quantities, as MC
and Eos numbers were uncompromised (Figure 6a). These
findings thus support our prior hypothesis (Elishmereni et al.,
2011; Elishmereni et al., 2013) (i) that AEU formation
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correlates with disease severity and (ii) that AEU occurrence
depends, at least partially, on 2B4-mediated binding. Of note,
in mice, a two-way CD48–2B4 communication between
MCs and Eos is plausible, as both receptors appear on
both cells (Elishmereni et al., 2013). The existence of a bi-
directional 2B4-CD48 interaction involving both stimulating
and inhibiting signals in MCs/Eos immensely complicates the
delineation of the CD48–2B4 role in inflammation. Future
work in CD48-deficient mice will provide a ‘mirror’ system for
corroborating and complementing our present conclusions.
Over the past few years, there has been increasing interest
in inhibitory MC/Eos molecules as therapeutic targets for
regulating allergy (Munitz and Levi-Schaffer, 2007; Karra
and Levi-Schaffer, 2011; Migalovich-Sheikhet et al., 2012;
Nissim Ben Efraim et al., 2013). Inhibiting functions revealed
for 2B4 suggest its addition to this arsenal. However, further
studies must clarify whether the complex 2B4 activation/
inhibition system displayed herein is paralleled in the
human setting (in either allergic, or other, immune effector
cells). In this case, optimal use of 2B4-targeting agents will
need to contemplate inhibitory effects while preventing
overstimulation.
MATERIALS AND METHODS
Mice
2B4 / mice, generated on the C57BL/6 (B6) background (Lee
et al., 2004), were obtained as a generous gift from the laboratory of
Professor V Kumar (University of Chicago, IL, USA). Age and gender-
matched wt B6 mice were purchased from Harlan Laboratories
(Jerusalem, IL). Mice were housed and bred in the Hebrew
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Figure 6. Chronic AD in 2B4 / mice: MC/Eos coupling. (a) Total and degranulating MCs, and infiltrating Eos, and (b) MC–Eos couples, in CTB- and
H&E-stained skin sections of wt and 2B4 / mice challenged with OVA/SEB (or phosphate-buffered saline in controls) under the chronic AD model.
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University of Jerusalem Animal Facilities, in specific pathogen-free
conditions. All murine experiments were approved by the Animal
Experimentation Ethics Committee of the Hebrew University of
Jerusalem.
Cell culture experiments
MCs and Eos were cultured from bone marrow progenitors of female
2B4 / and wt mice, and examined for maturity and phenotype after
4 and 2 weeks (respectively). In culture experiments, BMMCs were
activated by an IgE/DNP system, under 2B4 Ab–ligating or blocking
conditions (in wt), or under normal conditions (in 2B4 / ), and after
1h b-hexosaminidase release was evaluated in a chromogenic assay.
BMEos were activated by platelet activating factor under 2B4
Ab-ligation or blockade (in wt) or under normal conditions (in
2B4 / ); EPO release was measured after 1 hour by an enzymatic
assay, and surface molecule expression was evaluated after 48 hours by
flow cytometry. See complete procedures in Supplementary Materials
and Methods online.
In vivo inflammation models
Peritonitis was induced in male 10-week-old wt and 2B4 / mice
by i.p. injecting c48/80 or phosphate-buffered saline in control
groups. After 24 hours, peritoneal lavages were recovered for exami-
nation of cellular content by flow cytometry. AD was induced in
female 7-week-old mice (wt and 2B4 / ) by repeated epicutaneous
sensitization (Savinko et al., 2005; Wang et al., 2007), within a ‘mild’
(short-term) 22-day model, and in a ‘chronic’ (long-term) 50-day
model. For allergen exposure, mouse back skins were shaved, tape-
stripped, and a patch soaked in OVA/SEB or phosphate-buffered
saline (in controls) was applied, and later removed during resting
periods. At end points, mice were killed and skin samples were
processed for histology and immunohistochemistry. Skin-draining
lymph node content was assessed by flow cytometry, and sera
were examined for cytokines and IgE by ELISA and Luminex. See
Supplementary Materials and Methods online for full details.
Statistical analysis
All experiments were carried out at least three times, and data
were analyzed by two-tailed paired Student’s t-test assuming equal
variance, where P-values o0.05 were considered significant. Data
are reported as mean±SEMs.
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